Guidance

Antimicrobial intravenous-to-oral switch: criteria for prompt switch

National antimicrobial intravenous-to-oral switch (IVOS) criteria for prompt switch​ developed for adult and paediatric patients, categorised into 5 sections.

• From: UK Health Security Agency
• Published: 1 November 2022
• Last updated: 25 October 2024 — See all updates

Documents

National antimicrobial intravenous-to-oral switch (IVOS) criteria for prompt switch for adults

HTML

Antimicrobial IVOS decision aid for adults

PDF, 317 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Antimicrobial IVOS decision aid for adults: text alternative

HTML

National criteria for prompt intravenous-to-oral switch (IVOS) of antimicrobials in children and young people (including newborns)

Ref: GOV-16483

HTML

Antimicrobial intravenous-to-oral switch (IVOS) decision aid for paediatrics

Ref: GOV-16872

PDF, 76.3 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Antimicrobial IVOS decision aid for paediatrics: text alternative

Ref: GOV-17349

HTML

Details

In 2022, the IVOS criteria for adults were developed through collation of criteria from a sample of 45 acute hospital IVOS policies, completion of a rapid systematic literature review to validate selection of criteria, and a 4-step Delphi consensus-gathering process involving 279 multidisciplinary participants from all UK nations to agree evidence-based, UK-wide IVOS criteria for hospitalised adult patients.

In 2024, paediatric IVOS criteria were also developed. The 29 criteria were co-produced through a UK-wide consensus process involving 170 multidisciplinary participants.

These projects were led by the UK Health Security Agency (UKHSA)’s Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use and Sepsis Division, in collaboration with NHS England AMR Programme and UKHSA’s Behavioural Science and Insights Unit. 

Published 1 November 2022
Last updated 25 October 2024 + show all updates

1. 25 October 2024

   Added plain text alternative for 'Antimicrobial intravenous-to-oral switch (IVOS) decision aid for paediatrics' and additional links.

2. 24 June 2024

   Added decision guide for paediatrics.

3. 4 April 2024

   Added paediatric IVOS prompt early switch criteria. Changed attachment titles to specify for adult patients.

4. 1 February 2023

   Added IVOS decision aid.

5. 1 November 2022

   First published.